Merck & Co., Inc., MRK is in the exchange NYSE and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in USA, Merck & Co., Inc., MRK has a market cap of 172889.28. Since its IPO date on the 1/2/1970, Merck & Co., Inc., MRK performance year to date is 21.14%. Today Merck & Co., Inc., MRK has gained -0.10%, with a current price of 62.46.
Ownership of the company is 0.04% for insider ownership while institutional ownership is 74.80%. The management of the company have seen the company have a payout ratio of 99.50%. Return of assets are at 5.20%, with return on investment at 6.40%.
In terms of debt levels and profit levels, Merck & Co., Inc., MRK is seeing a long-term debt/equity of 0.55. While Total debt/equity is 0.56. With a profit margin of 13.00%, this is combined with a gross margin of 63.20%, and operating margin of 18.10%. Merck & Co., Inc. ability to meet debt levels, with a current ratio of 1.9, while the quick ratio is 1.5.
For the last year Merck & Co., Inc., MRK has seen a EPS growth of -61.60%. A performance for the year of 25.98%. The 52-week high is -1.69%, and the 52-week low is 33.39%. The average volume for Merck & Co., Inc., MRK is 7865300.
With a target price of 66.11, can Merck & Co., Inc., MRK reach this target? Looking at the value indicators of Merck & Co., Inc., MRK. Merck & Co., Inc. has a P/E of 34.21 and a forward P/E of 16.2. Perhaps the more useful indicator than P/E, is PEG which has a value of 5.45. Merck & Co., Inc. also has a P/S and a P/B of 4.38 and 3.99 respectively. For P/cash, Merck & Co., Inc. has a value of 14.61, while it is 36.41 for P/free cash flow.
At the current price of 62.46, Merck & Co., Inc. has a dividend yield of 2.95%. We see a return on equity of 11.60%.
Looking more long-term Merck & Co., Inc., is projected to get an EPS growth for the next five years of 6.27%. In the short-term an EPS growth of 2.85% in the next year is forecasted. This is after a EPS growth of -61.60% for this year and for the last five years a 41.50% growth has been seen.